The LDN Book: How a Little-Known Generic Drug - Low Dose Naltrexone - Could Revolutionize Treatment for Autoimmune Diseases, Cancer, Autism, Depression, and More
Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and depression, find relief. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity?
Low Dose Naltrexone explains the drugs origins, its primary mechanism, and the latest research from practicing physicians and pharmacists as compiled by Linda Elsegood of The LDN Research Trust, the worlds largest LDN charity organization with over 19,000 members worldwide. Featuring ten chapters contributed by medical professionals on LDNs efficacy and two patient-friendly appendices,Low Dose Naltrexone is a comprehensive resource for doctors, pharmacists, and patients who want to learn more about how LDN is helping people now, and a clarion call for further research that could help millions more.
Product details
- Paperback: 240 pages
- Publisher: Chelsea Green Publishing Co; 1 edition (8 March 2016)
- Language: English
- ISBN-10: 1603586644
- ISBN-13: 978-1603586641
- Product Dimensions: 15.3 x 1.3 x 22.9 cm
The Shipping charges include packing, shipping, forwarding and our agency charges.
The shipping charges given here are for national destinations.
